Want to see SE:ARCOMA full AI Analyst Report?

Arcoma AB (ARCOMA) Price & Analysis

0 Followers

ARCOMA Stock Chart & Stats

kr7.20

-kr0.40(-3.79%)

At close: Mar 06 4:00 PM EST

kr7.20

-kr0.40(-3.79%)

Day’s Range― - ―

52-Week Rangekr6.16 - kr10.85

Previous CloseN/A

Volume10.05K

Average Volume (3M)22.73K

Market Cap

kr128.49M

Enterprise Valuekr101.42M

Total Cash (Recent Filing)kr33.94M

Total Debt (Recent Filing)kr0.00

Price to Earnings (P/E)33.9

Beta0.20

Next Earnings

Aug 20, 2026

EPS Estimate

0.14

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.26

Shares Outstanding14,308,510

10 Day Avg. Volume31,356

30 Day Avg. Volume22,732

Financial Highlights & Ratios

PEG Ratio-0.36

Price to Book (P/B)1.41

Price to Sales (P/S)0.80

P/FCF Ratio8.02

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.55

Revenue Forecast (FY)kr135.00M

Bulls Say, Bears Say

Bulls Say

Balance Sheet StrengthArcoma's zero-debt balance sheet and solid equity provide long-term financial flexibility. This durable strength lowers refinancing and solvency risk, enabling the company to fund capex, service obligations and strategic initiatives during periodic revenue or margin pressure without relying on external leverage.

Strong Cash GenerationSustained operating and free cash flow gives Arcoma the ability to self-fund product development, service infrastructure and working capital. Robust cash conversion supports reinvestment in durable capabilities and cushions the business against cyclical dips, improving long-term resilience.

Recurring Aftermarket & Software RevenueA business model combining equipment sales with recurring service, parts and software revenue increases customer lifetime value and revenue visibility. The installed-base monetization supports steady cash flows, higher switching costs and margin support over multiple years versus one-time hardware sales alone.

Bears Say

Margin VolatilityLarge year-to-year swings in gross margin indicate structural cost or pricing pressures and reduce earnings predictability. Persistent volatility can erode investor and customer confidence, constrain reinvestment, and make long-term planning for R&D, service capacity and commercial expansion more difficult.

Recent Revenue WeaknessDeclining top-line trends suggest headwinds in product demand or market penetration. Sustained revenue contraction reduces scale benefits, slows installed-base growth that drives recurring service income, and limits ability to absorb fixed costs, making margin recovery harder over the medium term.

Small Scale / Limited ResourcesA small employee base constrains R&D throughput, commercial reach and operational redundancy. Limited scale increases dependence on partners, heightens execution risk for product launches and geographic expansion, and can slow responses to competitive or regulatory shifts over the next several months.

ARCOMA FAQ

What was Arcoma AB’s price range in the past 12 months?

Arcoma AB lowest stock price was kr6.16 and its highest was kr10.85 in the past 12 months.

What is Arcoma AB’s market cap?

Arcoma AB’s market cap is kr128.49M.

When is Arcoma AB’s upcoming earnings report date?

Arcoma AB’s upcoming earnings report date is Aug 20, 2026 which is in 17 days.

How were Arcoma AB’s earnings last quarter?

Arcoma AB released its earnings results on Apr 23, 2026. The company reported kr0.057 earnings per share for the quarter, missing the consensus estimate of kr0.18 by -kr0.123.

Is Arcoma AB overvalued?

According to Wall Street analysts Arcoma AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Arcoma AB pay dividends?

Arcoma AB does not currently pay dividends.

What is Arcoma AB’s EPS estimate?

Arcoma AB’s EPS estimate is 0.14.

How many shares outstanding does Arcoma AB have?

Arcoma AB has 14,308,510 shares outstanding.

What happened to Arcoma AB’s price movement after its last earnings report?

Arcoma AB reported an EPS of kr0.057 in its last earnings report, missing expectations of kr0.18. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Arcoma AB?

Currently, no hedge funds are holding shares in SE:ARCOMA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Arcoma AB

Arcoma AB is a global provider that designs, manufactures, and supplies cutting-edge radiology solutions. Their product line features advanced digital x-ray and radiography systems. These versatile systems are suitable for a wide array of radiographic applications and are utilized across various clinical environments, including general practice, musculoskeletal, thoracic, pediatric, and trauma/resuscitation units. The company distributes its products through a network of OEM partners. Arcoma AB was founded in 1990 and is headquartered in Växjö, Sweden.